IP Library › Granted Patent US 11,839,696
Granted Patent B2
US 11,839,696 · App. 16/577,890 · Granted Dec 12, 2023

Collagen scaffolds

Inventor: Martha M. Murray (Sherborn, MA)
Assignee: The Children's Medical Center Corporation
A61L27/24A61L27/3633A61L27/3691A61L27/56C07K14/78C12P21/00A61K38/00A61L2430/06A61L2430/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,696
App. No.
16/577,890
Granted
Dec 12, 2023
Kind
B2
Abstract

Methods for preparing and using collagen extracts and collagen scaffolds are provided. Additionally methods and related kits for the repair of articular tissue using the collagen material are provided.

Claims (33)

1. A collagen implant configured to repair tissue exposed to synovial fluid, the collagen implant comprising:

an implant body having a size and shape that is configured for implantation into an articular joint where synovial fluid is present, the implant body entirely comprised of a self-assembly of enzyme-solubilized collagen fibers comprising tropocollagen or atelocollagen, the collagen fibers having resistance to degradation by synovial fluid; and

wherein the collagen implant is a compressible and expandable material that is up to about 22 mm in diameter in an non-expanded state and has a collagen concentration of at least 10 mg/mL.

2. The collagen implant of claim 1 , wherein the collagen implant is expandable.

3. The collagen implant of claim 1 , further comprising calcium.

4. The collagen implant of claim 1 , wherein the collagen fibers comprise calcium.

5. The collagen implant of claim 1 , wherein the collagen implant is a sponge.

6. The collagen implant of claim 1 , wherein the collagen implant is capable of absorbing at least 3 ml of blood.

7. The collagen implant of claim 1 , wherein the collagen implant is capable of absorbing at least 9 ml of blood.

8. The collagen implant of claim 1 , wherein the collagen implant is cylindrical.

9. The collagen implant of claim 8 , wherein the collagen implant is about 22 mm in diameter.

10. The collagen implant of claim 8 , wherein the collagen implant is about 30 mm in length.

11. The collagen implant of claim 1 , wherein the collagen implant comprises collagen obtained from a bovine knee.

12. The collagen implant of claim 6 , comprising less than about 25 ug/g of nucleic acids per gram of collagen implant.

13. The collagen implant of claim 6 , comprising less than about 50,000 ng/g of DNA per gram of collagen implant.

14. The collagen implant of claim 6 , comprising less than about 5,000 uM/g of phospholipids per gram of collagen implant.

15. The collagen implant of claim 6 , comprising less than about 2,000 ug/g of GAG per gram of collagen implant.

16. The collagen implant of claim 1 , further comprising a therapeutic protein.

17. The collagen implant of claim 1 , comprising less than about 25 ug/g of nucleic acids per gram of collagen implant, less than about 50,000 ng/g of DNA per gram of collagen implant, less than about 5,000 uM/g of phospholipids per gram of collagen implant, and less than about 2,000 ug/g of GAG per gram of collagen implant, wherein the collagen implant is capable of absorbing at least 3 ml of blood.

18. The collagen implant of claim 1 , comprising less than about 25 ug/g of nucleic acids per gram of collagen implant, less than about 50,000 ng/g of DNA per gram of collagen implant, and less than about 5,000 uM/g of phospholipids per gram of collagen implant, wherein the collagen implant is capable of absorbing at least 3 ml of blood.

19. The collagen implant of claim 1 , comprising less than about 25 ug/g of nucleic acids per gram of collagen implant, less than about 50,000 ng/g of DNA per gram of collagen implant, and less than about 2,000 ug/g of GAG per gram of collagen implant, wherein the collagen implant is capable of absorbing at least 3 ml of blood.

20. A collagen implant configured to repair a ruptured ligament, the collagen implant comprising:

an implant body having a size and shape that is configured for implantation near the ruptured ligament, the implant body entirely comprised of a self-assembly of collagen fibers comprising tropocollagen or atelocollagen formed by heating a neutralized collagen slurry; wherein the neutralized collagen slurry has a collagen concentration of greater than 10 mg/ml; and

wherein the collagen implant is a compressible material and the collagen fibers have a resistance to degradation by synovial fluid.

21. The collagen implant of claim 20 , wherein the collagen fibers comprise calcium.

22. The collagen implant of claim 20 , wherein the collagen slurry comprises calcium.

23. The collagen implant of claim 20 , wherein the collagen implant is a sponge.

24. The collagen implant of claim 20 , wherein the collagen implant is cylindrical.

25. The collagen implant of claim 20 , further comprising a therapeutic protein.

26. The collagen implant of claim 20 , comprising less than about 25 ug/g of nucleic acids per gram of collagen implant, less than about 50,000 ng/g of DNA per gram of collagen implant, less than about 5,000 uM/g of phospholipids per gram of collagen implant, and less than about 2,000 ug/g of GAG per gram of collagen implant, wherein the collagen implant is capable of absorbing at least 3 ml of blood.

27. The collagen implant of claim 25 , wherein the one or more therapeutic proteins include one or more hormones, cytokines, growth factors, clotting factors, anti-protease proteins, angiogenic proteins, anti-angiogenic proteins, fibronectin, and bone morphogenic proteins.

28. The collagen implant of claim 1 , wherein the self-assembly of collagen fibers are not crosslinked.

29. The collagen implant of claim 20 , wherein the self-assembly of collagen fibers are not crosslinked.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2022
From: MURRAY, MARTHA M.
To: THE CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 062177/0331 →
Continuity (4)
Continuation 15679629 · Aug 17, 2017
Continuation 14765064
Provisional Application 61759868 · Feb 1, 2013
Related Publication 20200222586A1 · Jul 16, 2020